NEFL and myeloid sarcoma: After confirming the stability of NfL following a three-day delay in processing, we proceeded to extend this delay and examined the impact of a seven-day processing delay on analyte concentrations in plasma (B.1.b) and serum (B.2.b) from healthy controls, HD, and MS participants.